Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Mechanism to Form Influenza A Virus Discovered

By Instituto Gulbenkian de Ciencia | April 11, 2019

The influenza A virus is known to form new strains every year. These strains are the result of small variations occurring at the level of the genome, which cause the virus to become different and no longer recognized by the immune system. A new study by Maria João Amorim’s team, from the Gulbenkian Institute of Science, now reveals where the genomes of the influenza A virus are assembled inside infected cells. The results will be published this week in the journal Nature Communications and may contribute to therapies that prevent or combate new strains of influenza viruses.

Influenza A virus can only multiply within the cells of the body it infects, because it needs to use the cellular machinery of the host. When infection occurs, the virus enters into the cell and releases its genetic material and some proteins. But these viruses have an unusual peculiarity: their genome is segmented into eight distinct parts. Thus, during virus multiplication, the eight parts of the genetic material are replicated many times. The formation of new viruses requires that these eight segments are assembled into the same viral particle, which implies a very precise selection out of thousands of molecules that are mixed. Where this selection is made was unknown until now.

The study of the team of Maria João Amorim reveals that the selection of the genetic material is made in viral-induced compartments called viral inclusions. The researchers found that these compartments are not delimited by a membrane, as the traditional organelles in the cell. Instead, viral inclusions are separated from the surroundings by a process called liquid-liquid phase separation. This process is similar to what happens with vinegar and olive oil when placed together. In this way, the genetic material of the virus are segregated and confined to a small space where it is easier to assemble the sets of eight pieces that form the genome.

“Our results pave the way for alternative therapies that could target genome formation, or the place where the genome is formed,” Amorim said. The IGC researcher also explains that “this work is innovative because it is one of the initial observations that demonstrates that viral infections use phase separation processes.”

Phase separation in biology is a research area of increasing interest. Changes to this process are cause but also consequence of many diseases, mainly neurological diseases. The work published by the IGC team opens the door to investigate the role that phase separation plays in infections caused by influenza and other microorganisms.


Filed Under: Infectious Disease

 

Related Articles Read More >

Secretary of Health removes all current members of the CDC advisory committee on immunization practices
covid-19 vaccine
FDA COVID booster pullback jolts vaccine stocks before gains cool
Coronavirus Covid-19 background - 3d rendering
Pregnancy associated with less long COVID: Researchers call for studies on protective biology
How technology advances are helping scientists unlock the mysteries of zoonotic diseases
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE